Showing results (341-350 of 422) with videos related to
Sort By:
Pageof 43
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|May 15, 2019
Characteristics of Mid-Frequency Sensorineural Hearing Loss ProgressionJack Birkenbeuel, Mehdi Abouzari, Khodayar Goshtasbi, et al.American Journal of Otolaryngology|December 18, 2009
Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosisHarrison W Lin, Jeremy D Richmon, Kevin S Emerick, et al.Brain Sciences|November 11, 2022
Selective Neural Electrical Stimulation of an Injured Facial Nerve Using Chronically Implanted Dual Cuff ElectrodesArash Abiri, Steven Chau, Nathan R James, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|August 10, 2021
Association between modified frailty index and surgical outcomes in intradural skull base surgeryKhodayar Goshtasbi, Arash Abiri, Brandon M Lehrich, et al.Nature Protocols|January 9, 2019
A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannomaJie Chen, Lukas D Landegger, Yao Sun, et al.Annals of the Rheumatic Diseases|December 18, 2013
Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitisJonathan Kay, Roy Fleischmann, Edward Keystone, et al.BMC Family Practice|December 21, 2021
Patient perspectives on health care provider practices leading to an axial spondyloarthritis diagnosis: an exploratory qualitative research studyKate L Lapane, Catherine Dubé, Katarina Ferrucci, et al.Journal of Magnetic Resonance Imaging : JMRI|November 26, 2009
Retrospective assessment of prevalence of nephrogenic systemic fibrosis (NSF) after implementation of a new guideline for the use of gadobenate dimeglumine as a sole contrast agent for magnetic resonance examination in renally impaired patientsHani H Abujudeh, Hillary Rolls, Rathachai Kaewlai, et al.Nature Communications|February 11, 2026
NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing lossSimeng Lu, Zhenzhen Yin, Limeng Wu, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
Enhanced Tumor Control and Hearing Loss Prevention Achieved with Combined Immune Checkpoint Inhibitor and Anti-VEGF Therapy in Vestibular Schwannoma ModelSimeng Lu, Zhenzhen Yin, Limeng Wu, et al.Pageof 43